{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T22:12:20Z","timestamp":1778019140085,"version":"3.51.4"},"reference-count":10,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.eururo.2026.01.002","type":"journal-article","created":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T21:04:46Z","timestamp":1768424686000},"page":"394-395","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["The Discovery of Prostate-specific Membrane Antigen Ligands: The Long Road to Changes in Clinical Practice for Prostate Cancer"],"prefix":"10.1016","volume":"89","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8926-5376","authenticated-orcid":false,"given":"Martina","family":"Bene\u0161ov\u00e1-Sch\u00e4fer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Uwe","family":"Haberkorn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John W.","family":"Babich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.eururo.2026.01.002_b0005","first-page":"115","article-title":"The LNCaP cell line\u2014a new model for studies on human prostatic carcinoma","volume":"37","author":"Horoszewicz","year":"1980","journal-title":"Prog Clin Biol Res"},{"key":"10.1016\/j.eururo.2026.01.002_b0010","first-page":"927","article-title":"Monoclonal antibodies to a new antigenic marker in epithelial prostatic cells and serum of prostatic cancer patients","volume":"7","author":"Horoszewicz","year":"1987","journal-title":"Anticancer Res"},{"key":"10.1016\/j.eururo.2026.01.002_b0015","first-page":"3629","article-title":"Monoclonal antibodies to the extracellular domain of prostate-specific membrane antigen also react with tumor vascular endothelium","volume":"57","author":"Liu","year":"1997","journal-title":"Cancer Res"},{"key":"10.1016\/j.eururo.2026.01.002_b0020","doi-asserted-by":"crossref","first-page":"4022","DOI":"10.1158\/1078-0432.CCR-04-2690","article-title":"Radiolabeled small-molecule ligands for prostate-specific membrane antigen: in vivo imaging in experimental models of prostate cancer","volume":"11","author":"Foss","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.eururo.2026.01.002_b0025","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1007\/s00259-014-2713-y","article-title":"Radiation dosimetry and first therapy results with a 124I\/131I-labeled small molecule (MIP-1095) targeting PSMA for prostate cancer therapy","volume":"41","author":"Zechmann","year":"2014","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.eururo.2026.01.002_b0030","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.2967\/jnumed.115.171397","article-title":"PSMA-targeted radionuclide therapy of metastatic castration-resistant prostate cancer with 177Lu-labeled PSMA-617","volume":"57","author":"Kratochwil","year":"2016","journal-title":"J Nucl Med"},{"key":"10.1016\/j.eururo.2026.01.002_b0035","doi-asserted-by":"crossref","first-page":"649","DOI":"10.2967\/jnumed.118.219592","article-title":"A single dose of 225Ac-RPS-074 induces a complete tumor response in an LNCaP xenograft model","volume":"60","author":"Kelly","year":"2019","journal-title":"J Nucl Med"},{"key":"10.1016\/j.eururo.2026.01.002_b0040","doi-asserted-by":"crossref","first-page":"664","DOI":"10.2967\/jnumed.123.267189","article-title":"First-in-human 212Pb-PSMA-targeted \u03b1-therapy SPECT\/CT imaging in a patient with metastatic castration-resistant prostate cancer","volume":"65","author":"Griffiths","year":"2024","journal-title":"J Nucl Med"},{"key":"10.1016\/j.eururo.2026.01.002_b0045","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.trecan.2019.05.008","article-title":"Clonal evolution and epithelial plasticity in the emergence of AR-independent prostate carcinoma","volume":"5","author":"Laudato","year":"2019","journal-title":"Trends Cancer"},{"key":"10.1016\/j.eururo.2026.01.002_b0050","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/s41585-025-01014-w","article-title":"Targeting the tumour cell surface in advanced prostate cancer","volume":"22","author":"Boixareu","year":"2025","journal-title":"Nat Rev Urol"}],"container-title":["European Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283826000035?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283826000035?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T21:47:48Z","timestamp":1778017668000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0302283826000035"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":10,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S0302283826000035"],"URL":"https:\/\/doi.org\/10.1016\/j.eururo.2026.01.002","relation":{},"ISSN":["0302-2838"],"issn-type":[{"value":"0302-2838","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Discovery of Prostate-specific Membrane Antigen Ligands: The Long Road to Changes in Clinical Practice for Prostate Cancer","name":"articletitle","label":"Article Title"},{"value":"European Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eururo.2026.01.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 European Association of Urology. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}